The Verdict is Out: Trials Advance Ebola Vaccine

By militarymedical on March 19, 2018No Comment

Amy Shurtleff, Ph.D., works in a biosafety level 4 laboratory at USAMRIID. Shurtleff is part of a team that evaluated the protective efficacy of Merck's EBOV vaccine, V920. (Image courtesy of USAMRIID)